Among 9/11 responders, SBU sees PTSD-dementia link
By GREGORY ZELLER // The heroes of 9/11 continue to confront danger, according to a new study by Stony Brook University researchers that sees a potential connection between PTSD and…
Alzheimer’s disease
Grant backs NYU Winthrop’s out-of-the-skull thinking
By GREGORY ZELLER // A “surprise grant” from the Alzheimer’s Disease Resource Center will further some promising Alzheimer’s-related research underway at NYU Winthrop Hospital. The Mineola hospital’s Research Institute announced…
‘Dormant’ biotech wakes on Alzheimer’s fast track
By GREGORY ZELLER // A pre-clinical-stage biopharmaceutical company is being fast-tracked toward a potential Alzheimer’s treatment, after taking a decidedly slow road. Stony Brook-based Avanti Biosciences Inc. actually launched in…
ALZ: Genetic variants can run, but they can’t hide
The Feinstein Institute for Medical Research is targeting genetic risk factors behind Alzheimer’s disease, the first of many steps toward new potential treatments. Feinstein Institute assistant professor Yun Freudenberg-Hua has…
United it stands, with help from the Suffolk IDA
A 33-year-old biotech will purchase and renovate its longtime Hauppauge home, thanks to tax breaks approved Thursday by the Suffolk County Industrial Development Agency. Synthetic vaccine manufacturer United Biomedical Inc….